Conn. AG backs pharma-gift limits

For the second time in the past two years, Connecticut Attorney General Richard Blumenthal is urging legislation that requires strict limits and disclosure of gifts from drugmakers to doctors who may influence healthcare decisions. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.